According to current guidelines, it is important to screen first-degree relatives of patients with familial thoracic aortic aneurysm and dissection (FTAAD) using imaging techniques in order to detect any undiagnosed or asymptomatic cases. The current diagnostic methods for FTAAD involve clinical and instrumental diagnosis. In addition to these methods, genetic analysis through DNA testing, using a blood sample has become an essential tool. The use of massive parallel sequencing (NGS) of multiple genes or the entire exome (Whole Exome Sequencing - WES) is considered the gold standard for genetic diagnosis of FTAAD. However, it should be noted that linkage studies are not currently included in the diagnostic protocols of the Italian National Health System, although they may be helpful in complex familial cases where DNA sequencing has not provided conclusive evidence.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with ascending thoracic aortic aneurysms in the absence of a mutation identified by WES
Subjects with small and medium artery aneurysms in the absence of a mutation identified by WES
Relatives of individuals with ascending thoracic aortic aneurysms in the absence of a mutation identified by WES
Relatives of individuals with ascending thoracic aortic aneurysms in the absence of a mutation identified by WES
Signed informed consent
You may not be if
Subjects wit syndromic FTAAD with WES identified gene mutation
Subjects wit non-syndromic FTAAD with WES identified gene mutation